Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases — Dimitrios C. Ziogas (2017) | RDL Network
Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases
Letter 2017 en
Authors
DZ
Dimitrios C. Ziogas
ET
Evangelos Terpos
MG
Maria Gavriatopoulou
Abstract
1 min read
Multiple myeloma (MM) patients are considered severely immune-compromised and at high risk of opportunistic infections, independently of the therapeutic approach and the response status. Leishmania...
Discussion(0)
No comments yet. Be the first to comment.